SQZ Biotechnologies Company (SQZ) Stock Analysis
DELISTED 2023
What happened to SQZ Biotechnologies Company (SQZ) stock?
SQZ Biotechnologies Company (SQZ) no longer trades on public markets. It was delisted in July 2023. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- July 2023
- Last recorded price (historical):
- $0.435 (last quote on record before the July 2023 delisting; historical, not a current quote)
Market cap $12.8M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
SQZ Biotechnologies Company (SQZ). SQZ Biotechnologies is a clinical-stage biotechnology firm specializing in cell therapies for cancer, autoimmune, and infectious diseases. Their lead candidate, SQZ-PBMC-HPV, is undergoing Phase I trials for HPV16+ solid tumors.
Last analyzed: May 7, 2026SQZ Biotechnologies Company (SQZ) Healthcare & Pipeline Overview
More about this archive record
Can I still buy SQZ shares?
No. SQZ stopped trading on public markets in July 2023, so the shares are not available through a broker. Anything you see quoted for SQZ elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before SQZ stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to SQZ Biotechnologies Company. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.